Release Date: 24/05/23 13:47 Summary: Ceasing to be a substantial holder - T Sanders Price Sensitive: No Download Document 1.14MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%